High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.4M
$3,439,653
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
BCRX
S
BIOCRYST PHARMACEUTICALS INC
HEGGIE THERESA
• Director
Discretionary SellΔOwn -43.3%
2026-03-20
$504,823
|
||||||
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
Director
Discretionary SellΔOwn -43.3%
|
2026-03-20 | $504,823 | S | Form 4 |
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
Director
Other
|
2026-03-20 | $314,578 | M | Form 4 |
|
BCRX
M
BIOCRYST PHARMACEUTICALS INC
Barnes Alane P
• Officer • Chief Legal Officer
Other
2026-03-16
$826,500
|
||||||
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
Officer • Chief Legal Officer
Other
|
2026-03-16 | $826,500 | M | Form 4 |
|
BCRX
S
BIOCRYST PHARMACEUTICALS INC
Barnes Alane P
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -27.2%
2026-03-16
$1,372,500Large
|
||||||
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -27.2%
|
2026-03-16 | $1,372,500Large | S | Form 4 |
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
Director
Other
|
2026-03-02 | $985,304 | M | Form 4 |
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
President
Equity Compensation
|
2025-12-22 | $0 | M | Form 4 |
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
President
Equity Compensation
|
2025-12-22 | $0 | M | Form 4 |
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
President
Equity Compensation
|
2025-12-22 | $0 | M | Form 4 |
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
President
Other
|
2025-12-22 | $275,500 | M | Form 4 |
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
President
Other
|
2025-12-22 | $50,859 | M | Form 4 |
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
President
Other
|
2025-12-22 | $45,537 | M | Form 4 |
|
BCRX
S
BIOCRYST PHARMACEUTICALS INC
Barnes Alane P
• Officer • Chief Legal Officer
10b5-1 Sell
2025-12-22
$166,563
|
||||||
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2025-12-22 | $166,563 | S | Form 4 |
|
BCRX
S
BIOCRYST PHARMACEUTICALS INC
Barnes Alane P
• Officer • Chief Legal Officer
10b5-1 Sell
2025-12-15
$162,256
|
||||||
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2025-12-15 | $162,256 | S | Form 4 |
|
BCRX
S
BIOCRYST PHARMACEUTICALS INC
Barnes Alane P
• Officer • Chief Legal Officer
10b5-1 Sell
2025-12-03
$151,240
|
||||||
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2025-12-03 | $151,240 | S | Form 4 |
|
BCRX
S
BIOCRYST PHARMACEUTICALS INC
Barnes Alane P
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -12.2%
2025-12-02
$367,216
|
||||||
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -12.2%
|
2025-12-02 | $367,216 | S | Form 4 |
|
BCRX
M
BIOCRYST PHARMACEUTICALS INC
Barnes Alane P
• Officer • Chief Legal Officer
Equity Compensation
2025-12-01
$0
|
||||||
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
Officer • Chief Legal Officer
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
|
BCRX
S
BIOCRYST PHARMACEUTICALS INC
Barnes Alane P
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -17.9%
2025-12-01
$646,511
|
||||||
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -17.9%
|
2025-12-01 | $646,511 | S | Form 4 |
|
BCRX
M
BIOCRYST PHARMACEUTICALS INC
Barnes Alane P
• Officer • Chief Legal Officer
Other
2025-12-01
$293,033
|
||||||
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
Officer • Chief Legal Officer
Other
|
2025-12-01 | $293,033 | M | Form 4 |
|
BCRX
S
BIOCRYST PHARMACEUTICALS INC
SANDERS MACHELLE
• Director
10b5-1 SellΔOwn -23.9%
2025-11-13
$68,544
|
||||||
| BCRX |
BIOCRYST PHARMACEUTICALS INC
|
Director
10b5-1 SellΔOwn -23.9%
|
2025-11-13 | $68,544 | S | Form 4 |